Arne Mork

City:

Malov

Country:

Denmark

Published Applications:

Last publication date:

2016-03-24

Top Assignees for applications by Arne Mork

The entities that hold a legal rights for patent applications filed by inventor Mork Arne:

H. Lundbeck A/S 4 Copenhagen-Valby, Denmark
H. LUNDBECK A/S 3 Valby, Denmark
H. Lundbeck A/S 2 Valby-Copenhagen, Denmark
H. Lundbeck A/S 2 Valby-Coppenhagen, Denmark

Recent patent applications by Mork Arne

Arne Mork from Malov, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-03-24

US20160083359A1

Chemistry; metallurgy

1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND With COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT

#2 | 2015-01-01

US20150005318A1

Human necessities

1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HTand 5-HTactivity for the treatment of cognitive impairment

#3 | 2014-12-25

US20140377363A1

Chemistry; metallurgy

1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment

#4 | 2014-10-23

US20140315921A1

Chemistry; metallurgy

1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HTand 5-HTactivity for the treatment of cognitive impairment

#5 | 2014-09-04

US20140248356A1

Chemistry; metallurgy

1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HTand 5-HTactivity for the treatment of cognitive impairment

#6 | 2014-09-04

US20140248355A1

Chemistry; metallurgy

1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment

#7 | 2010-11-25

US20100297240A1

Human necessities

1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

#8 | 2009-02-26

US20090054510A1

Physics

METHOD FOR IDENTIFYING COMPOUNDS FOR THE TREATMENT OF DEPRESSION

#9 | 2008-01-03

US20080004338A1

Human necessities

USE OF ENANTIOMERIC PURE ESCITALOPRAM

#10 | 2005-12-29

US20050288355A1

Human necessities

Combination therapy wherein a serotonin reuptake inhibitor is used

InventorID:

895646 ⎘